<DOC>
	<DOCNO>NCT03045198</DOCNO>
	<brief_summary>In collaboration Dr.Birgit Alteheld , Institute Nutrional Sciences university Bonn , Germany follow effect explore : Effect 4 week therapy AZT synthesis lipoproteins well Docosahexaen fatty acid patient Cystic Fibrosis ( CF ) . Moreover proinflammatory cytokine blood sputum interest .</brief_summary>
	<brief_title>Effect Azithromycin Fatty Acids CF</brief_title>
	<detailed_description>The macrolide azithromycin ( AZT ) recommend Flume CF pulmonary Guidelines long-term treatment patient CF chronically colonize Pseudomonas aeruginosa due immunomodulating property . AZT cause significant reduction proinflammatory cytokine Lipopolysaccharid binding protein ( LBP ) accord Steinkamp Schmitt-Grohé . There inverse correlation LBP lung function . Moreover Schmitt-Grohé coworkers provide evidence positive correlation lipoprotein HDL lung function . Ribeiro coworkers find increased expression Lipid/Cholesterol gene primary human airway epithelial culture treatment AZT . Freedman coworkers able show decrease level Docosahexaen acid CF patient . The aim study explore impact 4 week trial AZT lipoprotein fatty acid ( docosahexaen acid etc . ) synthesis . Delta F508 homozygous patient receive AZT ( 10 mg/kg body weight resp . max 500 mg ) every Monday , Wednesday Friday 4 week . 20 patient ( age 10-60 year ) recruit . Fatty acid ( blood ) , cytokine ( whole blood induce sputum ) clinical parameter assess 4 week AZT treatment .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Delta 508 homozygous regularly visit CF outpatient clinic Bonn clinical laboratory sign ( CRP &gt; 20 mg/L ) exacerbation , treatment systemic steroid 14 day preceeding trial elevate liver function test ( &gt; twice normal range )</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>cystic fibrosis</keyword>
</DOC>